|
In September 2006, William Schary joined the company as Vice President of Regulatory Affairs and Quality Assurance. Dr. Schary's career spans various roles in regulatory affairs and quality assurance for numerous pharmaceutical companies. Dr. Schary has successfully filed more than 20 regulatory dossiers in the U.S., Europe, Canada, and Asia. He joined Sunesis from Valeant Pharmaceuticals International, where from 2003 to 2006 he held the position of Vice President of Regulatory Affairs and was responsible for all U.S. Food and Drug Administration (FDA) interactions, participated in strategic product planning and implemented quality control systems. Prior to Valeant, Dr. Schary served in regulatory and quality positions at Cellegy Pharmaceuticals, Aronex Pharmaceuticals, Takeda Pharmaceuticals, and CoCensys. He began his career as a reviewer with the Division of Biopharmaceutics, U.S. FDA. He received his Ph.D. degree in Pharmacokinetics from the University of Manchester in England, an M.S. degree in Pharmacology and Comparative Toxicology from the University of California, San Francisco, and a B.A. degree in Biology from the University of California, San Diego. | 